Age related prevalence of hepatitis G virus in South Africans

Citation
Mj. Mphahlele et al., Age related prevalence of hepatitis G virus in South Africans, J CLIN PATH, 52(10), 1999, pp. 752-757
Citations number
31
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
JOURNAL OF CLINICAL PATHOLOGY
ISSN journal
00219746 → ACNP
Volume
52
Issue
10
Year of publication
1999
Pages
752 - 757
Database
ISI
SICI code
0021-9746(199910)52:10<752:ARPOHG>2.0.ZU;2-Y
Abstract
Aim-To investigate the age related prevalence of hepatitis G virus (HGV) in fection and its mode of transmission in relation to hepatitis B (HBV) and C (HCV) coinfection in South African blacks. Methods-Reverse transcriptase polymerase chain reaction was performed to de tect active infection, using primers for the 5'-NCR, NS5a, and NS3 regions. Antibodies to HGV envelope-2 protein (anti-E2), which measures past infect ion, were also sought. Results-The overall prevalence of active infection was 116/580 (20%). A hig her prevalence was noted in HBsAg carriers (28/106; 26.4%) and HCV positive subjects (25/82; 30.5%). In contrast to developed countries, active and pa st infection was seen in 12.9% and 12.1% of the general population, respect ively (subjects negative for HBsAg and anti-HCV markers and with normal ala nine aminotransferase values), with a total prevalence of 21.1% (52/248). V iraemia and anti-E2 were almost mutually exclusive. The distribution of vir aemia by age was: less than or equal to 15 years, 20/223 (9.0%); 16-35 year s, 42/147 (28.6%); greater than or equal to 36 years, 37/151 (24.5%), with a significant difference (p=0.001) in age related prevalence. A similar tre nd was observed for the prevalence of past infection in the general populat ion. Conclusions-HGV infection begins in childhood and increases with age in Sou th Africa, but transmission is largely independent of HBV and HCV. No assoc iation was found between HGV viraemia and hepatitis, or with co-infection w ith either HBV or HCV.